Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 75 years old, of any nationality
- People who have been diagnosed with early-stage breast cancer
- People whose general health and ability to carry out daily activities falls within a certain acceptable range (confirm with trial site)
- People who are scheduled to receive a strong type of chemotherapy known to cause a high risk of nausea and vomiting
- People whose organs (such as kidneys and liver) are functioning at an adequate level
- Women who have not yet gone through menopause and are using appropriate birth control
Who may not be able to join:
- People who are scheduled to receive additional chemotherapy on days 2 to 4 after starting the strong chemotherapy
- People who have received, or are planned to receive, radiation therapy to the abdomen within one week before the first treatment day
- People with significant ongoing medical or psychological health conditions
- People who have a brain or nervous system cancer that is causing nausea or vomiting
- People who are already experiencing nausea or vomiting at a moderate or severe level before the trial begins
- People who have a known allergy to the study drug, anti-nausea medications, or the steroid dexamethasone
- People who are afraid of electroacupuncture (a type of needle-based therapy that uses mild electrical stimulation), or who are allergic to stainless steel needles
- People who have received acupuncture treatment for any reason within the 8 weeks before starting chemotherapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13639336037
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of Patients Free from Nausea Throughout Treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.